Maurizio Brunetti

763 total citations
16 papers, 604 citations indexed

About

Maurizio Brunetti is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Maurizio Brunetti has authored 16 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Genetics and 4 papers in Oncology. Recurrent topics in Maurizio Brunetti's work include Acute Myeloid Leukemia Research (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Maurizio Brunetti is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Maurizio Brunetti collaborates with scholars based in Italy and United States. Maurizio Brunetti's co-authors include Roberto Stasi, Sergio Amadori, Elisa Stipa, E. Terzoli, Tara S. Strigo, Barbara K. Rimer, Cary N. Robertson, Mark R. Conaway, Wendy Demark‐Wahnefried and Adalberto Pagano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Maurizio Brunetti

16 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurizio Brunetti Italy 11 373 180 152 97 71 16 604
José Villagra United States 5 233 0.6× 63 0.3× 231 1.5× 58 0.6× 73 1.0× 6 501
Susan Schulman United States 10 141 0.4× 184 1.0× 148 1.0× 154 1.6× 28 0.4× 15 576
Tomoko Tamaki Japan 9 159 0.4× 123 0.7× 65 0.4× 124 1.3× 129 1.8× 26 566
Laura Cannella Italy 13 286 0.8× 137 0.8× 186 1.2× 31 0.3× 65 0.9× 37 483
O. Gisserot France 8 129 0.3× 125 0.7× 167 1.1× 84 0.9× 143 2.0× 54 567
H. Goldschmidt Germany 11 265 0.7× 228 1.3× 60 0.4× 31 0.3× 147 2.1× 34 447
Kirsten Merx Germany 11 423 1.1× 140 0.8× 351 2.3× 93 1.0× 81 1.1× 35 692
Riccardo Centurioni Italy 15 457 1.2× 236 1.3× 93 0.6× 33 0.3× 156 2.2× 40 685
Elizabeth Blanchard United States 11 159 0.4× 184 1.0× 34 0.2× 132 1.4× 113 1.6× 23 531
Gladstone Airewele United States 13 511 1.4× 124 0.7× 246 1.6× 47 0.5× 223 3.1× 34 865

Countries citing papers authored by Maurizio Brunetti

Since Specialization
Citations

This map shows the geographic impact of Maurizio Brunetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurizio Brunetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurizio Brunetti more than expected).

Fields of papers citing papers by Maurizio Brunetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurizio Brunetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurizio Brunetti. The network helps show where Maurizio Brunetti may publish in the future.

Co-authorship network of co-authors of Maurizio Brunetti

This figure shows the co-authorship network connecting the top 25 collaborators of Maurizio Brunetti. A scholar is included among the top collaborators of Maurizio Brunetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurizio Brunetti. Maurizio Brunetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stasi, Roberto, Maria Laura Evangelista, Maurizio Brunetti, et al.. (2008). Primary Gastric Plasmacytoma and Helicobacter pylori Infection. Journal of Clinical Oncology. 27(1). 150–153. 17 indexed citations
2.
Stasi, Roberto, Maria Laura Evangelista, Maurizio Brunetti, et al.. (2008). Analysis of differential therapeutic strategies for primary breast lymphoma: two case reports. Medical Oncology. 26(1). 22–26. 6 indexed citations
3.
Pacella, Claudio Maurizio, Dario Valle, Giancarlo Bizzarri, et al.. (2006). Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II study. Acta Oncologica. 45(1). 77–83. 24 indexed citations
4.
Stasi, Roberto, Maurizio Brunetti, Elisa Stipa, & Sergio Amadori. (2004). Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood. 103(12). 4424–4428. 148 indexed citations
5.
Stasi, Roberto, Maurizio Brunetti, E. Terzoli, Elisabetta Abruzzese, & Sergio Amadori. (2004). Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing. Annals of Oncology. 15(11). 1684–1690. 19 indexed citations
6.
Rufini, Vittoria, Germano Perotti, Maurizio Brunetti, et al.. (2004). Unsuspected Testicular Metastases From Merkel Cell Carcinoma. American Journal of Clinical Oncology. 27(6). 636–637. 8 indexed citations
7.
Stasi, Roberto, Maurizio Brunetti, E. Terzoli, & Sergio Amadori. (2002). Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes. Blood. 99(5). 1578–1584. 36 indexed citations
8.
Stasi, Roberto, Maurizio Brunetti, Adalberto Pagano, et al.. (2000). Pulsed Intravenous High-Dose Dexamethasone in Adults with Chronic Idiopathic Thrombocytopenic Purpura. Blood Cells Molecules and Diseases. 26(6). 582–586. 39 indexed citations
9.
Stasi, Roberto, Adriano Venditti, Giovanni Del Poeta, et al.. (1998). Role of Human Leukocyte Interferon-α in the Treatment of Patients With Polycythemia Vera. The American Journal of the Medical Sciences. 315(4). 237–241. 7 indexed citations
10.
Stasi, Roberto, et al.. (1998). The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma. Cancer. 82(10). 1860–1866. 51 indexed citations
11.
Stasi, Roberto, et al.. (1997). Serum levels of tumour necrosis factor-α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome. Clinical & Laboratory Haematology. 19(3). 197–201. 37 indexed citations
12.
Stasi, Roberto, Maurizio Brunetti, S. Bussa, et al.. (1997). Efficacy and safety of human leucocyte interferon‐α treatment in patients younger than 60 years of age with polycythaemia vera. Journal of Internal Medicine. 242(2). 143–147. 5 indexed citations
13.
Stasi, Roberto, Maurizio Brunetti, S. Bussa, & Adalberto Pagano. (1997). Serum interleukin-10 in plasma-cell dyscrasias. American Journal of Hematology. 54(4). 335–337. 9 indexed citations
14.
Stasi, Roberto, et al.. (1997). Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome.. PubMed. 19(3). 197–201. 23 indexed citations
15.
Stasi, Roberto, Maurizio Brunetti, S. Bussa, et al.. (1997). Response to recombinant human erythropoietin in patients with myelodysplastic syndromes.. PubMed. 3(5). 733–9. 30 indexed citations
16.
Demark‐Wahnefried, Wendy, Tara S. Strigo, Mark R. Conaway, et al.. (1995). Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology. 46(3). 346–351. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026